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Background: Warm ischemic time (WIT) in kidney transplantation has signiﬁcant effects on graft sur-
vival, function, and postoperative morbidity. We utilized the Ice Bag Technique (IBT) to determine if
eliminating WIT would decrease the incidence and length of delayed graft function (DGF) in our cohort.
Methods: We conducted a prospective study of 150 kidney transplants. We compared the elimination of
WIT with IBT to traditional methods. Data was analyzed using non-parametric statistical tests.
Results: 66 of the 134 patients underwent transplantation using IBT. 28 right kidneys, 34 left kidneys,
and 4 dual kidneys were implanted successfully. Patients with a body mass index (BMI) as high as 41
were transplanted. Kidneys with up to three arteries and two veins, and kidneys up to 15.5 by 9 cm in
size were safely transplanted into either iliac fossa. Despite the complete elimination of WIT, there was
no difference in DGF, length of DGF, length of stay graft rejection, graft survival, patient survival, or
wound or urologic complications between groups (p > 0.05).
Conclusions: The elimination of warm ischemic time using the IBT does not appear to reduce the inci-
dence or length of DGF in this cohort. The technique may be useful for cases with prolonged anastomosis
time (AT), but further studies with larger cohorts are required to determine whether it decreases DGF.
 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
It is impossible to transplant an organwithout causing ischemia
and microcirculatory disturbance. These insults are established
causes of reperfusion injury and functional impairment [1e3].
Ischemia and reperfusion injury (IRI) are associated with an
increased rate of acute rejection, primary non-function (PNF),
delayed graft function (DGF), initial poor graft function (IPGF), and
late graft failure [1e4].
WIT refers to the time necessary to perform the vascular anas-
tamoses during kidney transplantation [1,4]. While WIT is an
accepted risk factor for DGF, we do not know the safe upper limit.
DGF is deﬁned as the requirement of dialysis within seven days of
transplantation. It is a negative prognostic indicator for long-term
allograft survival and is also associated with signiﬁcant costs. At-
tempts to minimize WIT include wrapping the kidney in an ice-
soaked laparotomy pad. Other techniques include using an RAY-gery, Albert Einstein Medical
A 19141, USA.
ni).
by Elsevier Ltd. All rights reservedTEC sponge (Johnson & Johnson, New Brunswick, NJ, USA), stocki-
nette, cooling jacket, or clear sterilized bag [5]. Some surgeons
eschew this technique, preferring to simply suture the vessels as
quickly as possible. However, this approach may lead to technical
errors, excessive bleeding, worse long-term outcomes, and a poor
learning experience for the resident staff [1]. The ice bag technique
is a method developed in the 1990’s to reduce WIT that was largely
abandoned before being studied in the literature. This technique
may potentially lead to less DGF. The aim of this study was to
evaluate the effect of the IBT on incidence and length of DGF. We
also sought to determine its effect on wound and urologic com-
plications as well as patient and graft survival.
2. Materials and methods
We conducted an Institutional Review Board e approved pro-
spective study of renal transplants performed between January
2010 and June 2011. 150 renal transplants were identiﬁed after
excluding allografts from living or infant donors. These were
excluded to provide uniformity to our cohort and because they
comprised an extremely small proportion of transplants. We also
wanted to show that the technique is safe with longer vessels,.
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We divided subjects into three arms: IBT, non-IBT due to surgeon
preference, and non-IBT for anatomic reasons. Informed consent
was waived by the local ethics committee. Cases performed by the
surgeon who preferred not to use the IBT served as the control
group. Patients in the anatomic limitation group were excluded
from statistical analysis. Reasons for exclusion from the IBT
included cut or short renal arteries or veins, difﬁcult arterial course,
duplicate arteries, recipient BMI, and limited operative space
(Table 1). The follow-up for these patients was one year, which was
chosen because our primary endpoint, DGF, would manifest within
that time frame.
Donor variables recorded include donor type (donation after
cardiac death or DCD, donors after neurologic determination of
death or DND, expanded criteria donors or ECD, and combined
ECD/DCD donors), donor gender, donor age, kidney side, size,
number of vessels, terminal creatinine and use of the machine
perfusion pump. We classiﬁed donor type by the Organ Procure-
ment and Transplantation Network (OPTN) deﬁnitions. We also
examined recipient demographics including body mass index
(BMI), comorbidities such as diabetes and hypertension, and pri-
mary renal disease. Intraoperative parameters included WIT, cold
ischemic time (CIT), and operative site. We deﬁned WIT, also
referred to as AT, as time from removal of the kidney from storage
to reperfusion with or without IBT. It is important to note that WIT
was eliminated with the IBT. Primary endpoints included incidence
and length of DGF. The length of DGF was deﬁned as the duration
between transplant date and last dialysis session. Secondary end-
points included creatinine levels on postoperative days 10 and 365,
graft rejection, graft and patient survival, length of hospital stay
(LOS), wound complications and urologic complications. Creatinine
levels at postoperative day 10 were chosen as this is the usual
postoperative nadir value. We also collected data on postoperative
day 365 creatinine as it is routinely collected by UNOS and is an
excellent predictor of long-term allograft outcome. Renal allograft
loss was deﬁned as death with a functioning graft, allograft ne-
phrectomy or resumption of dialysis. Wound complications
included fascial dehiscences, wound dehiscences, and wound in-
fections. Wound infection was deﬁned as infection of the skin or
subcutaneous tissues surrounding the surgical wound. Urologic
complications examined include urosepsis and urine leaks. Results
were compiled into a series of Excel databases to be analyzed at the
end of the speciﬁed time period. Due to the small size of the group,
patients in the anatomical exclusion cohort were unable to be
statistically compared to the patients in the IBT and non-IBT cohort
and were thus excluded from statistical analysis.
All procedures were in accordancewith the Helsinki Declaration
of 1975.
2.1. The Ice Bag Technique
After back table preparation, the allograft was placed in an ice-
ﬁlled bag with an outlet for the renal artery and vein. A Kelly clampTable 1
Reasons for anatomic exclusion.
Anatomic reasons for exclusion Number (n)
Arteries cut 1 (6%)
Short arteries 3 (18%)
Difﬁcult arterial course 1 (6%)
Ice bag failure 3 (18%)
Short renal vein 1 (6%)
Duplicate arteries 2 (12%)
Too small space 1 (6%)
BMI 3 (18%)was employed to maintain the ﬂuid and ice in place and to function
as a handle (Fig. 1). The handle was always placed on the inferior
(ureteral) side of the graft for orientation. A penetrating towel
clamp afﬁxed the kidney to one side of the wound while the
anastomoses were performed (Fig. 2). After completion of the
anastomoses, the vascular clamps were removed and the bag was
cut and passed off the ﬁeld. At no timewas there evidence of loss of
the cooling properties of the ice bags or frostbite leading to injured
kidney parenchyma in the IBT group.
2.2. Patient management protocols
All patients were immunosuppressed with Prograf (Tacrolimus,
Astellas Pharma, Deerﬁeld IL), Cellcept (Mycophenolate Mofetil,
Roche, Nutley NJ) and prednisone. Anti-thymocyte globulin (ATG,
Genzyme) was the most common agent used for induction therapy,
followed by the IL-2 receptor antibody (Daclizumab). ATG was
dosed at 1.5 mg/kg per day for 4e7 days starting intraoperatively
through a central line and titrated for leukopenia, thrombocyto-
penia or other side effects attributed to the induction. The goal dose
ranged between 5 and 6 mg/kg. Acetaminophen, diphenhydramine
and steroids were given before all infusions. All patients were
started on Mycophenolate Mofetil with doses ranging from 1 to 2 g
per day. The dosagewas titrated for gastrointestinal side effects and
leukopenia. Patients received methylprednisolone 400e500 mg IV
intraoperatively followed by a prednisone taper to 30 mg daily by
day 7, 20 mg daily by day 30 and 5 mg daily by day 90. Tacrolimus
was started by day 4. Target trough levels ranged between 5 and
12 ng/ml. For Pneumocystis jiroveci pneumonia prophylaxis, all
patients received one single strength trimethoprim/sulfamethox-
azole daily for at least 6 months post transplant, and 3months afterFig. 1. Ice Bag Technique: The kidney is introduced into the bag with ice and a small
hole was made near the hilum through which the renal artery and vein were passed. A
Kelly clamp was used to maintain the ﬂuid and ice in place as a handle.
Fig. 2. Ice Bag Technique during anastamosis. The kidney placed in an ice bag is
introduced into the ﬁeld with a penetrating towel clamp afﬁxed to one side of the
wound while the anastamoses are performed.
F. Karipineni et al. / International Journal of Surgery 12 (2014) 551e556 553
ORIGINAL RESEARCHevery rejection episode. In patients with sulfa allergies Dapsone or
aerosolized pentamidine was employed. Fungal prophylaxis was
provided by oral clotrimazole or nystatin for 2 months post-
transplant. For Cytomegalovirus (CMV) prophylaxis all patients
received at least 3 months of valgancyclovir with doses ranging
from 450 mg every other day to 900 mg daily, depending on renalTable 2
Donor variables.
Variable
Donor Type, n (%) DCD
DND
ECD
ECD/DCD
Donor Kidney, n (%) Right
Left
Both
Gender, n (%) Male
Female
Number of arteries in donated kidney, n (%) One
Two
Three
Four
Number of veins in donated kidney, n (%) One
Two
Normal number of arteries and veins in donated kidney, n (%) Normal
Multiple
Donor Age (y), Mean (SD)
Terminal Creatinine, Mean (SD)
Machine perfusion, n (%)
DCD ¼ Donation after cardiac death; DND ¼ donor after neurologic death; ECD ¼ expanfunction and established risk factors. CMV prophylaxis was re-
instituted for three months after every rejection episode.
All rejection episodes were biopsy proven and the Banff 97
classiﬁcation was used to grade each biopsy specimen. Grade 1
cellular rejections were treated with intravenous methylpredniso-
lone. Recalcitrant Grade 1 and all Grade 2 cellular rejections were
treated with 5e6 mg/kg of ATG. Intravenous pulse steroids, ATG,
intravenous immunoglobulin and plasmapheresis were employed
for clinically signiﬁcant antibody mediated rejections.2.3. Statistical analysis
SAS was used for the statistical analysis. A Wilcoxon rank sum
test and Chi-square test were applied for numerical and categorical
data respectively because most of the risk factors were normally
distributed. Non-parametric statistical methods were used to
determine whether or not the ice bag technique had an effect on
the incidence and duration of DGF. We deﬁned the null hypothesis
as no difference between the IBT and non-IBT populations with
respect to incidence and length DGF. KaplaneMeier analysis was
also used to analyze graft survival data.
Due to the small sample size and many DGF associated risk
factors, univariate logistic regression was utilized to reduce the
dimension of risk factors. After univariate logistic regression anal-
ysis, signiﬁcant risk factors were included in a multivariate logistic
regression model. For the two-group comparison, categorical var-
iables were analyzed using the Fisher exact and Chi-square tests.
Continuous variables were analyzed using nonparametric methods
because our continuous variables were not normally distributed. A
p-value of 0.05 was considered statistically signiﬁcant.3. Results
There were a total of 134 transplants in the analysis, 66 in the ice
bag group and 68 in the control group. Baseline donor and recipient
demographics as well as perioperative variables are depicted in
Tables 2 and 3. There was no difference in recipient characteristics,
perioperative variables or postoperative outcomes between the
two groups.Total observation numbers, N, are 134
IBT (N1 ¼ 66) (49%) Non-IBT (N2 ¼ 68) (51%) P-value
13 (19.7%) 25 (36.8%) 0.03
42 (63.6%) 37 (54.4%) 0.28
6 (9.1%) 5 (7.4%) 0.71
4 (6.1%) 0 (0%) 0.04
28 (42.4%) 35 (51.5%) 0.29
34 (51.5%) 33 (48.5%) 0.73
4 (6.1%) 0 (0%) 0.04
50 (75.8%) 42 (61.8%) 0.08
16 (24.2%) 26 (38.2%)
54 (81.8%) 56 (82.4%) 0.94
11 (16.2%) 9 (13.2%) 0.58
1 (1.5%) 2 (2.9%) 0.57
0 (0%) 1 (1.5%) 0.32
62 (93.9%) 63 (92.6%) 0.77
4 (6.1%) 5 (7.4%)
52 (78.79%) 53 (77.94%) 0.91
14 (21.21%) 15 (22.06%)
42.8  3.47 (14.09) 40.25  3.61 (14.92) 0.5
1.02  0.12 (0.42) 1.03  0.09 (0.51) 0.98
16 (44.4%) 20 (55.6%) 0.49
ded donor criteria; SD ¼ standard deviation.
Table 3
Recipient and perioperative variables.
Total observation numbers, N, are 134 P-value
IBT (N1 ¼ 66) (49%) Non-IBT (N2 ¼ 68) (51%)
Age at time of transplant (years), Mean (SD) 54.11  2.6 (10.59) 54.89  2.79 (11.5) 0.62
Kidney Sizes (Length Width) Cm, Mean 11.63  5.36  1.34  1.01 11.53  5.63  1.32  1.00 0.43
BMI (kg/m2), Mean (SD) 26.67  1.3 (5.22) 26.97  1.13 (4.59) 0.98
Site of incision, n (%) Right 55 (83%) 59 (87%) 0.33
Left 10 (15%) 8 (12%)
Midline 1 (2%) 1 (1%)
EBL (mL), Mean (SD) 191.23  22.86 (82.97) 179.3  21.12 (84.23) 0.37
WIT (min), Mean (SD) 30.46  1.33 (5.00) 29.56  1.27 (5.08) 0.19
CIT (hours), Mean (SD) 13.73  1.35 (5.45) 14.69  1.35 (5.56) 0.36
Total Procedure Time (min), Mean (SD) 191.92  15.91 (64.19) 177.97  8.16 (33.7) 0.43
Creatinine at POD 10, Mean (SD) 3.75  0.76 (3.10) 4.16  0.83 (3.44) 0.43
1 Year Creatinine, Mean (SD) 1.64  0.2 (0.7) 1.91  0.43 (1.5) 0.19
DGF 27 (52%) 25 (48%) 0.67
AVG Length DGF, Mean (SD) 7.89  3.59 (9.07) 10.25  3.99 (9.45) 0.21
Rejection within 1 year Total, n (%) 6 (9.1%) 10 (14.7%) 0.32
Length of Stay, Mean (SD) 11.38  2.01 (8.16) 10.52  1.52 (6.23) 0.41
Recipient Deaths (1 Year), n (%) 5 (7.6%) 2 (2.9%) 0.23
Graft Survival (1 Year), n (%) 60 (90.9%) 64 (94.1%) 0.48
Recipient HTN Status 50 (76.92%) 57 (83.82%) 0.32
Recipient diabetes status 27 (40.91%) 26 (38.81%) 0.80
Wound complication 9 (13.64%) 3 (4.41%) 0.07*
Urologic complications 3 (4.55%) 1 (1.47%) 0.36*
*Fisher exact test.
CIT ¼ Cold ischemic time; WIT ¼Warm ischemic time; EBL ¼ estimated blood loss.
SD ¼ Standard deviation, BMI ¼ Body mass index, IgA ¼ Immunoglobulin A.
*Subject excluded from length of stay due to non transplant complications.
Table 4a
Univariate analysis of risk factors for delayed graft function.
Variable p-value
AA 0.4822
Ice Bag 0.6710
WIT 0.2336
CIT 0.1630
ECD 0.6528
Obesity 0.9597
EBL 0.3128
Normal vessel 0.3724
Donor terminal creatinine 0.4731
Pumped 0.3512
Total duration of operation 0.3070
Donor age 0.0233
DCD 0.0301
ECD/DCD 0.6526
DND 0.0136
Table 4b
Multivariate analysis of risk factors for delayed
graft function.
Variable p-value
Intercept 0.0628
Donor age 0.0464
DCD 0.1942
DND 0.9318
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The rate of DGF in this cohort was 52% for IBT and 48% for non-
IBT. The mean length of DGF was 7.9 days for IBT and 10.2 days for
non-IBT. The difference in the rate and length of DGF between
groups was not statistically signiﬁcant (p ¼ 0.67 and p ¼ 0.21,
respectively) (Table 3). The use of the IBT did not correlate with
increasing or decreasing rate or length of DGF (p > 0.05). In uni-
variate analysis, donor age, (p ¼ 0.02), DCD (p ¼ 0.03) and DND(p ¼ 0.01) were signiﬁcantly associated with DGF (Table 4a).
Multivariate analysis predicted only donor age (p ¼ 0.046) to have
an effect on DGF (Table 4b).
3.2. Ischemic times
We measured WIT/AT for both groups, although WIT was
technically eliminatedwith IBT.WIT was 30.46min in the IBT group
and 29.56min in the non-IBTgroup. Therewas no difference inWIT
or CIT between the two groups (p¼ 0.19 and p¼ 0.36, respectively).
3.3. Patient outcomes
There was no difference in mean length of stay between the two
groups (p ¼ 0.41). The difference in incidence of wound compli-
cations between groups was also not statistically signiﬁcant
(p ¼ 0.07). The IBT group had two cases of urosepsis and one urine
leak, while the control group had one case of urosepsis and no urine
leaks. There was no statistical difference between the two groups
(p ¼ 0.36). There was no statistically signiﬁcant difference in one-
year rejection rates between the two groups (p ¼ 0.32). There
was no signiﬁcant difference in graft survival at 1 year (p ¼ 0.48) or
patient death at 1 year (p¼ 0.23) between the two groups. Kaplane
Meier analysis conﬁrmed no difference in graft survival.
3.4. Anatomic exclusion arm
A summary of the characteristics of cases in the anatomic
exclusion arm can be found in Table 1. Of the 15 patients in this
cohort, the most common reason for exclusion from IBT was
vascular anomalies. One patient was excluded because the renal
artery was cut during procurement. Three patients were excluded
due to short renal arteries leading to difﬁcult anastomoses. Another
three patients had a tortuous arterial course from the hilum of the
kidney. One patient had a short renal vein, which made ice bag
preparation and anastomoses difﬁcult. Another patient was
F. Karipineni et al. / International Journal of Surgery 12 (2014) 551e556 555
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for the artery. In three cases, the ice bag was damaged during the
anastomosis. Another patient had a small iliac fossa, which made it
difﬁcult to position the kidney appropriately.
4. Discussion
Ischemic reperfusion injury associated with WIT leads to DGF.
The consequences of prolonged DGF include increased length of
hospital stay and costs associated with treatments such as dialysis.
While WIT is a known risk factor for DGF, the upper limit of WIT
beyond which allograft dysfunction arises is unknown. Our study
shows that eliminating warm ischemic time with the use of the ice
bag technique does not reduce the incidence or length of DGF in
DCD, DND, ECD or ECD/DCD donors in our cohort. The IBT is also not
associated with decreased length of stay or a decrease in wound or
urologic complications, graft rejection or patient death.
Ischemic reperfusion injury is thought to result from an
imbalance in metabolic supply and demand within the ischemic
organ [6]. Ischemia results in tissue hypoxia and microvascular
dysfunction. Reperfusion extends the insult by activation of innate
and adaptive immune responses and cell death programs [7]. WIT
limits as low as 30 min [8] and as high as 50 min [9] have been
advocated for acceptable graft function. Also problematic is the fact
that no large study has systematically examined the effect of donor
category on WIT. Importantly, WIT is not consistently documented
in the UNOS database. While the true upper limit of WIT is un-
known, prolongedWIT has an established associationwith delayed
graft function and adverse outcomes [8].
Many studies have attempted to document the importance of
reducing WIT. Feuillu et al. [10] showed that allograft temperature
rises 0.48 C per minute and is 26.7 C by the end of the anasto-
mosis, therefore emphasizing the importance of meticulous ex vivo
preparation and minimal anastomosis time. Szostek et al. [11]
observed an increased incidence of delayed graft function when
kidney temperature was greater than 15 C, suggesting that
increased temperature is associated with developing DGF. Gavela
Martinez et al. retrospectively studied patients who developed DGF
and found prolonged anastomosis time to be a risk factor [12].
To prevent graft damage associated with warm ischemia,
various methods of reducing WIT have been reported. A Polish
group attempting to eliminate WIT described a complex poly-
ethylene receptacle that requires six hours to sterilize and contains
three separate containers allowing for storage and performance of
anastomoses [5]. This method is too complex for routine practice,
and the article does not report an association between use of the
device and lower rates of DGF. By contrast, the ice bag is a relatively
simple method of eliminating WIT with negligible equipment,
preparation time and manipulation of treatment protocols. A
recently study described the use of regional hypothermia during
robotic kidney transplantation to reduce WIT during the learning
curve required for robotic vascular anastomoses [13]. However, this
study focused on technique and did not address DGF.
While our study shows that eliminating WIT with the IBT did
not provide any advantage in our cohort, it may still be an impor-
tant technique. Because the upper limit of WIT that leads to un-
complicated kidney transplantation is unknown, reducing WIT
with the ice bag technique may still be of some beneﬁt. Further-
more, there are instances where anastomosis time is excessive due
to technical or anatomic difﬁculties. Recipients with large body
habitus and allografts with multiple vessels may have prolonged
AT. Our study displays that the IBT can successfully be used in dual
kidney transplants, multiple organ transplants, and kidneys with
multiple vessels. We were able to transplant a right or left donor
kidney into either fossa using the IBT. The technique was successfulin large kidneys and recipients with a BMI as high as 41. In these
cases, the IBT can function to preserve the organ during a long
anastomosis. It is a transparent device, allowing for excellent
orientation of the kidney and visualization of the anastomoses.
Total operative time was not prolonged. While this study served as
a proof of principle, we are planning a randomized controlled trial
with larger sample sizes to determine whether the IBT has any role
in decreasing DGF in kidney transplantation.
4.1. Strengths and limitations
Strengths of this study include its prospective design and one-
year follow-up period. Furthermore, our cohort size was large
enough to perform statistical analysis.
There were several limitations to our study. The transplants in
the two arms were performed by different surgeons, introducing
the possibility of confounding by differences in surgeon preference
and technique. The control group was generally comprised of sur-
geons who did not favor the IBT, introducing signiﬁcant bias. We
did not have long-term outcomes on this cohort and therefore
cannot comment on possible complications several years after
transplantation. Also, despite affording the possibility of statistical
analysis, our cohort size was too small and too heterogeneous to
provide clinically meaningful conclusions. In order to statistically
address the effect of the IBT on incidence of DGF, we would need at
least 650 patients to achieve adequate power for statistical analysis.
Lastly, our study design was not a randomized prospective clinical
trial, because our control group was based on surgeon preference.
Hence, potential bias may have been introduced in addition to
relative lack of power and instability of the univariate and multi-
variate models.
5. Conclusion
Elimination ofWIT using the IBT seems not to affect incidence or
length of DGF in our cohort. The technique is not associated with
decreased postoperative complications. Various types of kidney
transplants can be safely performed with this technique, and it may
be useful in cases with prolonged anastomosis time due to
anatomic or technical difﬁculties. Larger studies with IBT will be
necessary in order to truly determine whether the elimination of
WIT decreases the incidence and length of DGF.
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